Anti-CEL2A/ CELA2A/ ELA2A functional antibody

Anti-CEL2A/ CELA2A/ ELA2A functional antibody for cell culture, ELISA & in-vivo assay

Target products collectionGo to CELA2A/CELA2A products collection >>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)


Product information

Catalog No.Product NameSpecies Reactivity
GM-Tg-hg-SE0755-Ab-1/ GM-Tg-hg-SE0755-Ab-2Anti-Human CELA2A monoclonal antibodyHuman
GM-Tg-rg-SE0755-Ab-1/ GM-Tg-rg-SE0755-Ab-2Anti-Rat CELA2A monoclonal antibodyRat
GM-Tg-mg-SE0755-Ab-1/ GM-Tg-mg-SE0755-Ab-2Anti-Mouse CELA2A monoclonal antibodyMouse
GM-Tg-cynog-SE0755-Ab-1/ GM-Tg-cynog-SE0755-Ab-2Anti-Cynomolgus/ Rhesus macaque CELA2A monoclonal antibodyCynomolgus/ Rhesus macaque
GM-Tg-felg-SE0755-Ab-1/ GM-Tg-felg-SE0755-Ab-2Anti-Feline CELA2A monoclonal antibodyFeline
GM-Tg-cang-SE0755-Ab-1/ GM-Tg-cang-SE0755-Ab-2Anti-Canine CELA2A monoclonal antibodyCanine
GM-Tg-bovg-SE0755-Ab-1/ GM-Tg-bovg-SE0755-Ab-2Anti-Bovine CELA2A monoclonal antibodyBovine
GM-Tg-equg-SE0755-Ab-1/ GM-Tg-equg-SE0755-Ab-2Anti-Equine CELA2A monoclonal antibodyEquine

Size: 1mg | 10mg | 100mg



Product Description

Catalog No.GM-Tg-hg-SE0755-Ab-1/ GM-Tg-hg-SE0755-Ab-2; GM-Tg-rg-SE0755-Ab-1/ GM-Tg-rg-SE0755-Ab-2;
GM-Tg-mg-SE0755-Ab-1/ GM-Tg-mg-SE0755-Ab-2; GM-Tg-cynog-SE0755-Ab-1/ GM-Tg-cynog-SE0755-Ab-2;
GM-Tg-felg-SE0755-Ab-1/ GM-Tg-felg-SE0755-Ab-2; GM-Tg-cang-SE0755-Ab-1/ GM-Tg-cang-SE0755-Ab-2;
GM-Tg-bovg-SE0755-Ab-1/ GM-Tg-bovg-SE0755-Ab-2; GM-Tg-equg-SE0755-Ab-1/ GM-Tg-equg-SE0755-Ab-2
Products NameAnti-CELA2A monoclonal antibody
Formatmab
Target NameCELA2A
Protein Sub-locationSecreted Protein/Potential Cytokines
Category of antibodyFACS/Biofunctional Antibody
Derivation (species)Mouse
CH1+2+3 Isotype
(Receptor identification)
IgG
Type of Light Chain (VD-LC)N/A
Expression platformMammalian Expression
Bioactivity validationBinding affinity is validated by ELISA with recombinant soluble protein antigen. The biofunction of antibodies are validated with in-vitro assay (IC50 or EC50 TBD).
TagFc
Products descriptionPre-made anti-CELA2A benchmark inhibitory monoclonal antibody(mab) (blocking antibody inhibitor) is expressed by mammalian cell line as a benchmark antibody for cell culture, ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic)
Purity Purity: ≥95% (SDS-PAGE)
Application Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research.
Formulation & Reconstitution Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4);
For PSB2, reconstituted with 0.9% sodium chloride;
For PBS, reconstituted with ddH2O.
Storage Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Reference




    Data / case study


    Click to get more Data / Case study about the product.



    Associated products


    CategoryCat No.Products Name
    Target AntigenGM-Tg-g-SE0755-Ag-1Recombinant multi-species CEL2A/ CELA2A/ ELA2A protein
    ORF Viral VectorpGMLPm003228mouse Cela2a Lentivirus plasmid
    ORF Viral VectorvGMLPm003228mouse Cela2a Lentivirus particle


    Target information

    Target IDGM-SE0755
    Target NameCELA2A
    Gene ID63036,13706
    Gene Symbol and SynonymsAOMS4,CELA2A,Ela-2,Ela2,ELA2A,PE-1
    Uniprot AccessionP08217
    Uniprot Entry NameCEL2A_HUMAN
    Protein Sub-locationSecreted Protein/Potential Cytokines
    Category
    DiseaseN/A
    Gene EnsemblENSG00000142615
    Target ClassificationN/A

    The target: CELA2A, gene name: CELA2A, also named as ELA2A, PE-1. Elastases form a subfamily of serine proteases that hydrolyze many proteins in addition to elastin. Humans have six elastase genes which encode the structurally similar proteins elastase 1, 2, 2A, 2B, 3A, and 3B. Like most of the human elastases, elastase 2A is secreted from the pancreas as a zymogen. In other species, elastase 2A has been shown to preferentially cleave proteins after leucine, methionine, and phenylalanine residues. [provided by RefSeq, May 2009].



    About Gmab

    GDU
    GDU



    GMab, developed by GeneMedi, constitutes an advanced library of recombinant monoclonal antibodies, each meticulously designed to target specific molecular entities. Leveraging the sophisticated capabilities of GM’s Taurus™ and LIBRA™ platforms, GMab synthesizes antibodies characterized by high binding affinity, exceptional physicochemical stability, and optimal developability profiles.

    Through expression in mammalian cell lines, GMab has been established as a paradigmatic reference antibody. It holds significance in myriad domains of biological drug discovery, encompassing cellular cultivation, innovative assay methodologies, strategic animal model systematization, in-depth pharmacokinetic & pharmacodynamic (PK/PD) modeling, and intricate mechanism of action (MOA) investigations.